CONMED Corporation (CNMD) key performance indicators and operating metrics (9 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Diluted Earnings Per Share (Non-Generally Accepted Accounting Principles) | 0.89 USD_per_share | FY2026-Q1 |
| Gross Profit Margin | 57.90 percent | FY2026-Q1 |
| Operating Income Margin | 8.00 percent | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization Margin (Non-Generally Accepted Accounting Principles) | 17.80 percent | FY2026-Q1 |
| Earnings Before Interest, Taxes, Depreciation and Amortization Margin | 14.00 percent | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Non-Generally Accepted Accounting Principles) | 56.39M | FY2026-Q1 |
| Earnings Before Interest, Taxes, Depreciation and Amortization | 44.25M | FY2026-Q1 |
| Net Sales Growth in Constant Currency | 6.30 percent | FY2025-Q3 |
| Domestic Revenue Growth Year Over Year | 5.90 percent | FY2025-Q3 |
Back to CNMD overview · CNMD earnings · CNMD holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.